TY - JOUR
T1 - Aspartylglucosaminuria in a Puerto Rican family
T2 - Additional features of a panethnic disorder
AU - Chitayat, D.
AU - Nakagawa, S.
AU - Marion, R. W.
AU - Sachs, G. S.
AU - Hahm, S. Y.E.
AU - Goldman, H. S.
PY - 1988
Y1 - 1988
N2 - We report on 3 Puerto Rican brothers with the clinical and laboratory findings of aspartylglucosaminuria (AGU). Their parents were first cousins. The affected sibs have the 'cardinal' manifestations of AGU, including developmental disabilities, progressive 'coarsening' of the face, and early onset of hepatosplenomegaly. Biochemical studies showed elevated levels of urinary aspartylglucosamine and very low activity of aspartylglucosaminidase (AGA) in cultured fibroblasts. With long term follow-up, previously undescribed manifestations were noted, including radiographic evidence of spondylolysis and spondylolisthesis in early childhood and development of macro-orchidism during puberty. This family shows that AGU is not limited to individuals of Finnish background, but that the gene is panethnic in distribution and that additional changes, not previously noted, may present with advancing age.
AB - We report on 3 Puerto Rican brothers with the clinical and laboratory findings of aspartylglucosaminuria (AGU). Their parents were first cousins. The affected sibs have the 'cardinal' manifestations of AGU, including developmental disabilities, progressive 'coarsening' of the face, and early onset of hepatosplenomegaly. Biochemical studies showed elevated levels of urinary aspartylglucosamine and very low activity of aspartylglucosaminidase (AGA) in cultured fibroblasts. With long term follow-up, previously undescribed manifestations were noted, including radiographic evidence of spondylolysis and spondylolisthesis in early childhood and development of macro-orchidism during puberty. This family shows that AGU is not limited to individuals of Finnish background, but that the gene is panethnic in distribution and that additional changes, not previously noted, may present with advancing age.
UR - http://www.scopus.com/inward/record.url?scp=0023716303&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0023716303&partnerID=8YFLogxK
U2 - 10.1002/ajmg.1320310307
DO - 10.1002/ajmg.1320310307
M3 - Article
C2 - 3228136
AN - SCOPUS:0023716303
SN - 1552-4825
VL - 31
SP - 527
EP - 532
JO - American Journal of Medical Genetics, Part A
JF - American Journal of Medical Genetics, Part A
IS - 3
ER -